SB 24-060

  • Colorado Senate Bill
  • 2024 Regular Session
  • Introduced in Senate Jan 19, 2024
  • Senate
  • House
  • Governor

Prescription Drug Affordability Board Exempt Orphan Drugs

Abstract

The bill states that the Colorado prescription drug affordability review board has no authority to perform an affordability review of, or to establish an upper payment limit for, any prescription drug that is designated as a drug for a rare disease or condition by the federal food and drug administration. (Note: This summary applies to this bill as introduced.)

Bill Sponsors (3)

Votes


No votes to display

Actions


Apr 15, 2024

Senate

Senate Second Reading Laid Over to 05/09/2024 - No Amendments

Apr 08, 2024

Senate

Senate Second Reading Laid Over to 04/15/2024 - No Amendments

Apr 02, 2024

Senate

Senate Second Reading Laid Over to 04/08/2024 - No Amendments

Apr 01, 2024

Senate

Senate Second Reading Laid Over Daily - No Amendments

Mar 18, 2024

Senate

Senate Second Reading Laid Over to 04/01/2024 - No Amendments

Mar 11, 2024

Senate

Senate Second Reading Laid Over to 03/18/2024 - No Amendments

Feb 27, 2024

Senate

Senate Second Reading Laid Over to 03/11/2024 - No Amendments

Feb 22, 2024

Senate

Senate Committee on State, Veterans, & Military Affairs Refer Unamended to Senate Committee of the Whole

  • Committee-Passage
  • Referral-Committee
State, Veterans, & Military Affairs Senate Committee of the Whole

Jan 19, 2024

Senate

Introduced In Senate - Assigned to State, Veterans, & Military Affairs

  • Introduction
State, Veterans, & Military Affairs

Bill Text

Bill Text Versions Format
Introduced (01/19/2024) PDF
Committee Amendment PDF

Related Documents

Document Format
Fiscal Note FN1 (01/29/2024) PDF
Fiscal Note FN2 (02/09/2024) PDF
Fiscal Note FN3 (05/29/2024) PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Colorado General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.